Pay in 4 interest-free payments of $56.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
developing therapeutic interventions
enabling enzymatic chain extension
the target of abundant naturally occurring human anti-Gal antibodies and central to xenotransplantation and anti-Gal immunology research
13 / HHV1-gB(UniProt ID P08665) synthetic glycopeptide HSV1-gB fragment (Gly50-Pro56
PE134010: β-GalNAc-PEG3-Azide label-new developing therapeutic interventionsC14H26N4O9 378. 38 A D N acetylgalactosamine (GalNAc) ligand equipped with an azide handle through a hydrophilic PEG3 spacer. The terminal azide couples to alkynes via copper catalyzed azide alkyne cycloaddition (CuAAC) or to DBCO and related strained alkynes via copper free click chemistry, forming stable 1,2,3 triazole linkages. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the
